Zahra Shajani-Yi

Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non–Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing

Zahra Shajani-Yi, Francine B. de Abreu, Jason D. Peterson et al. · Neoplasia · 2018 · 62 citations · Full text

AACC Guidance Document on Management of Point-of-Care Testing

James H. Nichols, David Alter, Yu Chen et al. · The Journal of Applied Laboratory Medicine · 2020 · 52 citations

Nursing, Primary Care, Point-of-care Testing +6

Reference intervals and diagnostic ranges for serum free κ and free λ immunoglobulin light chains vary by instrument platform: Implications for classification of patient results in a multi-center study

Steven W. Cotten, Zahra Shajani-Yi, Mark A Cervinski et al. · Clinical Biochemistry · 2018 · 40 citations

Reference Intervals, Biomarker (Medicine), Disease Progression +10

An Intact ACTH LC-MS/MS Assay as an Arbiter of Clinically Discordant Immunoassay Results

Junyan Shi, Pawan Dhaliwal, Yu Zi Zheng et al. · Clinical Chemistry · 2019 · 29 citations · Full text

Reported Awareness and Adoption of 2021 Estimated Glomerular Filtration Rate Equations Among US Clinical Laboratories, March 2022

Jonathan R. Genzen, Rhona J. Souers, L. Pearson et al. · JAMA · 2022 · 16 citations · Full text

Renal Pathology, Clinical Laboratories, Cystatin C +23